x Health Men's Health Children's Health Nutrition and Wellness Reproductive Health Health & Science Digital News Videos Opinions Cartoons Education E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Travelog TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise BULK SMS E-Learning Digger Classified The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
Login ×
BTV
VAS
DCX
RMS

Hope as Kenya to try corona drug on patients

Health & Science - By Gatonye Gathura | July 28th 2020 at 12:00:00 GMT +0300

Kenya will start testing the only-approved Covid-19 drug on patients in the coming days.

The drug, known as remdesivir, costs Sh253,000 per treatment.

Dr Loice Achieng Ombajo, the head of infectious diseases unit at Kenyatta National Hospital (KNH), said a World Health Organisation (WHO) sponsored study on remdesivir will not be testing chloroquine, or the HIV drugs - lopinavir and ritonavir - as had been proposed earlier.

Dr Achieng, the study principal investigator, was addressing doctors from all over the country in a webinar organised by KNH to share experiences in treating Covid-19 patients.

The study, approved earlier this month, will be carried out at the Coast General Hospital, KNH, Aga Khan University Hospital, Nairobi Hospital, Kilifi Kemri-Wellcome, Moi Teaching and Referral Hospital, and Kenyatta University Hospital.

Remdesivir, an injectable manufactured by the Gilead Sciences of United States, is the only drug authorised for treatment of Covid-19 patients by the US Food and Drug Administration and European Medicines Agency. Initially, the drug had been developed for the treatment of Ebola.

Preliminary data from various clinical studies have shown the drug to reduce hospitalisation period in some Covid-19 patients by about four days.

In the US, the manufacturer has tagged the price of remdesivir, which is in short supply, at $2,340 (about Sh 253,000) for a full treatment.

Top Stories

Artificial melanin: New-age hair dye
Health & Science - By Killiad Sinide


The strike is still on, clinical officers say
Health & Science - By Rosa Agutu


Pfizer coronavirus jab chairman 'not sure' if it can stop people spreading virus
Health & Science - By Mirror


More needs to be done in Aids fight, says CS
Health & Science - By Peterson Githaiga


Doctors defy Ojaamong’ calls for dialogue, vow to strike
Health & Science - By Ignatius Odanga


Covid-19: Kenya records 866 new infections and six deaths
Health & Science - By Mercy Asamba


Corona jab will be here by February, says PS
Health & Science - By Kagundu Njiru


Lab-grown meat goes on sale for first time
Health & Science - By Damian Carrington


Covid-19: Kenya records 1,253 new coronavirus cases
Health & Science - By Vincent Kejitan


Calls for increased TB funding as cases rise
Health & Science - By Phares Mutembei


Latest Stories

Doctors defy Ojaamong’ calls for dialogue, vow to strike
Health & Science - By Ignatius Odanga


Pfizer coronavirus jab chairman 'not sure' if it can stop people spreading virus
Health & Science - By Mirror


Covid-19 vaccine may give people immunity for 90 days, scientists estimate
Health & Science - By Mirror


Coronavirus claims 1.5 million lives globally with 10,000 dying each day
Health & Science - By Reuters


State disputes 'very high' risk tag
Health & Science - By Graham Kajilwa


Agony for cancer patients who can no longer earn, socialise
Health & Science - By Mercy Kahenda


Coronavirus claims 1.5 million lives globally
Health & Science - By Reuters


Couple: We beat stigma and now live positively
Health & Science - By Titus Too


Covid-19: Kenya records 866 new infections and six deaths
Health & Science - By Mercy Asamba


The strike is still on, clinical officers say
Health & Science - By Rosa Agutu


//

Stay Ahead!

Access premium content only available
to our subscribers.

Support independent journalism
×
Log in
Support independent journalism
Create an account    Forgot Password
Create An Account
Support independent journalism
I have an account Log in
Reset Password
Support independent journalism
Log in